Riskpilot← Back to searchSign inGet full accessAXC Medical AB
ABActiveOrg 5592606296Economic activity was not specified by tax authority · NACE 0000Est. 20200 employees
Revenue 2024
SEK 0
EBITDA margin
—
-591% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
SEK 62K
+496% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -7K | -591% |
| Net profit | SEK 62K | +496% |
| Total assets | SEK 10,6M | +1% |
| Equity | SEK 10,6M | +1% |
| Employees | 0 | — |
Legal name
AXC Medical AB
Org number
5592606296
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
24 juni 2020
Share capital
SEK 28 936
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska vara ett Holdingbolag för investeringar i medicinetekniska bolag, vårdbolag och Biotechbolag samt därmed förenlig verksamhet.
Address
Email
karl.xavier@axcapital.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | −2 | — | −1 | −7 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 0 | −2 | 0 | −1 | −7 |
| Net financials | — | — | — | 13 | 84 |
| Profit before tax | 0 | −2 | 0 | 12 | 78 |
| Tax | −0 | −0 | — | −2 | −16 |
| Net profit | 0 | −2 | 0 | 10 | 62 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 575 | 9 324 | 9 324 | 10 526 | 10 598 |
| Equity | 7 575 | 9 324 | 9 324 | 10 514 | 10 575 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 0 | 0 | — | 12 | 22 |
| Total debt | — | — | — | 12 | 22 |
EBITDA margin
-686600.0%
This company
15.8%
Market median
-4345670% vs market
20202024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
0.6%
This company
18.4%
Market median
-97% vs market
20202024
Net profit margin
6155700.0%
This company
8.1%
Market median
+75996196% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-06-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2023 | |
| Chairman | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AXC Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Ivar Andersson Xavier | Board of Directors | 0 companies |
| Henrik Ingemar Palmér | Deputy Board Member | 0 companies |
| Stephanie Wuan Li Xavier | Deputy Board Member | 0 companies |
| Arash Jamali | Chairman | 0 companies |